Degree of exposure to psychotropic medications and mortality in people with bipolar disorder
- 21 October 2022
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (2), 186-197
- https://doi.org/10.1111/acps.13509
Abstract
Objectives To investigate the associations between psychotropic medication dosage and mortality in patients with bipolar disorder. Methods A nationwide cohort of individuals aged >= 15 years who had received a diagnosis of bipolar disorder in 2010 was identified from the Taiwanese national health-care database linked with the mortality registry and followed up for 5 years. The mean defined daily dose (DDD) of mood stabilizers, antipsychotics, antidepressants, and sedative-hypnotics was estimated, and survival analyses were conducted to assess the effects of degree of exposure to psychotropic medications on mortality. Results A total of 49,298 individuals (29,048 female individuals, 58.92%) with bipolar disorder were included. Compared with individuals without exposure to mood stabilizers, those prescribed mood stabilizers had a decreased overall mortality risk, regardless of exposure dosage. By contrast, compared with a reference group with no exposure to antipsychotics, individuals using antipsychotics had dose-dependent, increased mortality in both overall causes of deaths and deaths due to cardiovascular diseases, with hazard ratios of 1.13 (95% CI: 1.21-1.42) in the low-dose (1.5 DDD) group for overall mortality. Conclusions In sum, mood stabilizers were associated with decreased overall mortality in individuals with bipolar disorder, regardless of the dosage. However, the use of antipsychotics appeared to be associated with a dose-dependent increased mortality risk. Owing to study limitations, precise information on prior use of psychotropic medications, and patient's adherence to medication are not available. Potential adverse effects and benefits should be carefully considered when prescribing psychotropic medications for long-term use in patients with bipolar disorder.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 107‐2314‐B‐418‐014; MOST 109‐2314‐B‐418 ‐010;)
This publication has 48 references indexed in Scilit:
- All-Cause Mortality and Medication Risk Factors in SchizophreniaJournal of Clinical Psychopharmacology, 2012
- Psychotropic medications and the risk of sudden cardiac death during an acute coronary eventEuropean Heart Journal, 2011
- Antidepressants and Risks of Suicide and Suicide AttemptsBritish Journal of Psychology, 2011
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Development of Lifetime Comorbidity in the World Health Organization World Mental Health SurveysArchives of General Psychiatry, 2011
- All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort studyBMC Psychiatry, 2010
- Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar DisorderPsychosomatic Medicine, 2009
- Suicidal events and accidents in 216 first-episode bipolar I disorder patients: Predictive factorsJournal of Affective Disorders, 2008
- Effectiveness of Adjunctive Antidepressant Treatment for Bipolar DepressionThe New England Journal of Medicine, 2007
- Burden of general medical conditions among individuals with bipolar disorderBipolar Disorders, 2004